Quantcast

Latest Inhaler Stories

2014-06-24 23:06:47

According to a new report from BCC Research, the global market for pulmonary drug delivery systems is expected to grow to $43.9 billion by 2018 with a compound annual growth rate (CAGR) of 6.2% from 2013 to 2018. The dry powder inhalers category is the fastest moving segment in this market, growing at a significant five-year CAGR of 12.5%. (PRWEB) June 24, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, PULMONARY DRUG DELIVERY SYSTEMS: TECHNOLOGIES AND GLOBAL...

2014-06-18 12:32:44

--Data indicate ASM-024 DPI safe and generally well-tolerated in asthma-- QUEBEC CITY, Quebec, June 18, 2014 /PRNewswire/ -- Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of novel, proprietary compounds that target cholinergic receptors for the treatment of pulmonary diseases, today announced top-line results from a combined Phase 1 and 2a trial evaluating its lead compound, ASM-024, in moderate asthma patients. The data comes from Asmacure's recently...

2014-05-22 23:04:45

Markets Research Reports.biz added deep and professional market research reports on "Ovarian Cancer Therapeutics To 2020" analysis and overview. (PRWEB) May 22, 2014 “Ovarian Cancer Therapeutics to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free Survival and Targeted Therapies”. The current Ovarian cancer therapeutics market is dominated by the use of generics – predominately carbonation and facilitate, which are used in combination for the treatment of...

2014-05-21 13:45:48

American Thoracic Society Reminders prompting asthma patients to take their control inhalers if they miss a dose significantly improve medication adherence, according to a primary-care based study conducted by a research team in Australia. In this six-month investigation, patients receiving reminders took on average 73% of their prescribed doses compared to only 46% in patients who did not have reminders. The results of the cluster randomized controlled trial were presented at the ATS...

2014-05-21 08:30:11

Company expands digital health platform and services to include real-time video consultations SAN DIEGO, May 21, 2014 /PRNewswire/ -- American Thoracic Society International Conference (ATS 2014) -- Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, today announced the company will offer inhaler technique coaching via Helpouts by Google. People with asthma, COPD, or other chronic respiratory disease, and their family caregivers, can get...

2014-05-15 04:22:31

OXFORD, England, May 15, 2014 /PRNewswire/ -- First full presentation of data from randomised clinical study of glycopyrronium bromide made using Prosonix' novel particle-engineering technology Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that it will present results from its Phase 2 clinical study with PSX1002 in patients with moderate to severe chronic obstructive...

2014-05-06 08:34:19

New low-energy sensor eliminates charging, while enhanced analytics identify worsening patients MADISON, Wis., May 6, 2014 /PRNewswire/ -- World Asthma Day -- Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, today announced U.S. Food and Drug Administration 510(k) clearance to market its latest generation of the Propeller platform, including a new sensor. http://photos.prnewswire.com/prnvar/20140506/84619 Propeller is a digital therapeutic...

2014-05-02 23:05:28

Live webinar to focus on the interaction between inhalation powders and capsules shells, giving guidance to formulators on how best to tackle potential challenges. The broadcast takes place on Thursday, May 22, 2014 at 9:00 EDT (14:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) May 02, 2014 This webinar will explore the relationship between dry powder inhalers and hard capsules, how to match them together to give good powder aerosolization and delivery of the active ingredient deep into the...

2014-04-15 08:29:35

OXFORD, England and PITTSBURGH, April 15, 2014 /PRNewswire/ -- Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, today announced that it has entered into a global licensing agreement with Mylan Inc. (Nasdaq: MYL), one of the world's leading global pharmaceutical companies, for its leading inhaled respiratory products, PSX1001 and PSX1050. PSX1001 and PSX1050, which are the first products to emerge from Prosonix's...

2014-04-11 12:24:06

DUBLIN, Ireland, April 11, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/53hl65/global) has announced the addition of the "Global Epinephrine Auto-Injector Market Report" [http://www.researchandmarkets.com/research/53hl65/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Epinephrine Auto-injector market to grow at a CAGR of 13.34 percent over the...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related